{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:25:59Z","timestamp":1777987559340,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI110527, MD007593, MD007586"],"award-info":[{"award-number":["AI110527, MD007593, MD007586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DA037779"],"award-info":[{"award-number":["DA037779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI110527, MD007593, MD007586"],"award-info":[{"award-number":["AI110527, MD007593, MD007586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DA024558, DA30896, DA033892, DA021471, MD007586, DA042348, AI22960"],"award-info":[{"award-number":["DA024558, DA30896, DA033892, DA021471, MD007586, DA042348, AI22960"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI110527, MD007593, MD007586"],"award-info":[{"award-number":["AI110527, MD007593, MD007586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cocaine use is associated with breach in the blood brain barrier (BBB) and increased HIV-1 neuro-invasion. We show that the cellular enzyme \u201cProlidase\u201d plays a key role in cocaine-induced disruption of the BBB. We established a barrier model to mimic the BBB by culturing human brain microvascular endothelial cells (HBMECs) in transwell inserts. In this model, cocaine treatment enhanced permeability of FITC-dextran suggesting a breach in the barrier. Interestingly, cocaine treatment increased the activity of matrix metallo-proteinases that initiate degradation of the BBB-associated collagen. Cocaine exposure also induced prolidase expression and activity in HBMECs. Prolidase catalyzes the final and rate-limiting step of collagen degradation during BBB remodeling. Knock-down of prolidase abrogated cocaine-mediated increased permeability suggesting a direct role of prolidase in BBB breach. To decipher the mechanism by which cocaine regulates prolidase, we probed the inducible nitric oxide synthase (iNOS) mediated phosphorylation of prolidase since mRNA levels of the protein were not altered upon cocaine treatment. We observed increased iNOS expression concurrent with increased prolidase phosphorylation in cocaine treated cells. Subsequently, inhibition of iNOS decreased prolidase phosphorylation and reduced cocaine-mediated permeability. Finally, cocaine treatment increased transmigration of monocytic cells through the HBMEC barrier. Knock-down of prolidase reduced cocaine-mediated monocyte transmigration, establishing a key role of prolidase in cocaine-induced breach in endothelial cell barrier.<\/jats:p>","DOI":"10.1038\/s41598-018-37495-6","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T11:03:34Z","timestamp":1550833414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A Novel Role of Prolidase in Cocaine-Mediated Breach in the Barrier of Brain Microvascular Endothelial Cells"],"prefix":"10.1038","volume":"9","author":[{"given":"Binah baht","family":"Ysrayl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthukumar","family":"Balasubramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ife","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui","family":"Pandhare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandravanu","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"37495_CR1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","volume":"67","author":"JC McArthur","year":"2010","unstructured":"McArthur, J. C., Steiner, J., Sacktor, N. & Nath, A. Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol. 67, 699\u2013714 (2010).","journal-title":"Ann Neurol."},{"key":"37495_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-6405-11-13","volume":"11","author":"VR Rao","year":"2014","unstructured":"Rao, V. R., Ruiz, A. P. & Prasad, V. R. Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther. 11, 11\u201313 (2014).","journal-title":"AIDS Res Ther."},{"key":"37495_CR3","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/35073667","volume":"410","author":"M Kaul","year":"2001","unstructured":"Kaul, M., Garden, G. A. & Lipton, S. A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410, 988\u201394 (2001).","journal-title":"Nature."},{"key":"37495_CR4","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1086\/344528","volume":"186","author":"A Nath","year":"2002","unstructured":"Nath, A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis. 186, S193\u20138 (2002).","journal-title":"J Infect Dis."},{"key":"37495_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/2049-9256-2-2","volume":"2","author":"M Sanmarti","year":"2014","unstructured":"Sanmarti, M. et al. HIV-associated neurocognitive disorders. J Mol Psychiatry. 2, 2 (2014).","journal-title":"J Mol Psychiatry."},{"key":"37495_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11065-009-9102-5","volume":"19","author":"SP Woods","year":"2009","unstructured":"Woods, S. P., Moore, D. J., Weber, E. & Grant, I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 19, 152\u201368 (2009).","journal-title":"Neuropsychol Rev."},{"key":"37495_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/13803395.2013.783000","volume":"35","author":"SM Patel","year":"2013","unstructured":"Patel, S. M. et al. The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals. J Clin Exp Neuropsychol. 35, 421\u201334 (2013).","journal-title":"J Clin Exp Neuropsychol."},{"key":"37495_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/322130a0","volume":"322","author":"AT Haase","year":"1986","unstructured":"Haase, A. T. Pathogenesis of lentivirus infections. Nature. 322, 130\u2013136 (1986).","journal-title":"Nature."},{"key":"37495_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0042-6822(85)90246-6","volume":"147","author":"R Peluso","year":"1985","unstructured":"Peluso, R., Haase, A., Stowring, L., Edwards, M. & Ventura, P. A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology. 147, 231\u2013236 (1985).","journal-title":"Virology."},{"key":"37495_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1089\/apc.2008.0022","volume":"22","author":"BW Pence","year":"2008","unstructured":"Pence, B. W. et al. Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast. AIDS Patient Care STDS. 22, 869\u2013877 (2008).","journal-title":"AIDS Patient Care STDS."},{"key":"37495_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0165-1781(92)90108-F","volume":"41","author":"G Pakesch","year":"1992","unstructured":"Pakesch, G. et al. Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users. Psychiatry Res. 41, 163\u2013177 (1992).","journal-title":"Psychiatry Res."},{"key":"37495_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/00002030-199604000-00012","volume":"10","author":"GM Goodwin","year":"1996","unstructured":"Goodwin, G. M., Pretsell, D. O., Chiswick, A., Egan, V. & Brettle, R. P. The Edinburgh cohort of HIV-positive injecting drug users at 10 years after infection: a case-control study of the evolution of dementia. AIDS. 10, 431\u2013440 (1996).","journal-title":"AIDS."},{"key":"37495_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/135502801300069737","volume":"7","author":"A Nath","year":"2001","unstructured":"Nath, A., Maragos, W. F., Avison, M. J., Schmitt, F. A. & Berger, J. R. Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol. 7, 66\u201371 (2001).","journal-title":"J Neurovirol."},{"key":"37495_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neubiorev.2008.01.004","volume":"32","author":"MJ Ferris","year":"2008","unstructured":"Ferris, M. J., Mactutus, C. F. & Booze, R. M. Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci. Biobehav Rev. 32, 883\u2013909 (2008).","journal-title":"Neurosci. Biobehav Rev."},{"key":"37495_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1874473710902020143","volume":"2","author":"LR Norman","year":"2009","unstructured":"Norman, L. R., Basso, M., Kumar, A. & Malow, R. Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. Curr Drug Abuse Rev. 2, 143\u201356 (2009).","journal-title":"Curr Drug Abuse Rev."},{"key":"37495_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/02791072.1993.10472272","volume":"25","author":"EP Larrat","year":"1993","unstructured":"Larrat, E. P. & Zierler, S. Entangled epidemics: cocaine use and HIV disease. J Psychoactive Drugs. 25, 207\u2013221 (1993).","journal-title":"J Psychoactive Drugs."},{"key":"37495_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/13550280590952835","volume":"11","author":"M Fiala","year":"2005","unstructured":"Fiala, M. et al. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J Neurovirol. 11, 281\u2013291 (2005).","journal-title":"J Neurovirol."},{"key":"37495_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4615-5347-2_22","volume":"437","author":"M Fiala","year":"1998","unstructured":"Fiala, M. et al. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine\u2019s connection to AIDS dementia and vasculitis? Adv Exp Med Biol. 437, 199\u2013205 (1998).","journal-title":"Adv Exp Med Biol."},{"key":"37495_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fphar.2012.00121","volume":"3","author":"SM Kousik","year":"2012","unstructured":"Kousik, S. M., Napier, T. C. & Carvey, P. M. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol. 3, 121 (2012).","journal-title":"Front Pharmacol."},{"key":"37495_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh, P., Braun, A. & Nedergaard, M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 16, 1\u201313 (2004).","journal-title":"Neurobiol Dis."},{"key":"37495_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/13550280902769764","volume":"15","author":"NS Ivey","year":"2009","unstructured":"Ivey, N. S., MacLean, A. G. & Lackner, A. A. Acquired immunodeficiency syndrome and the blood-brain barrier. J Neurovirol. 15, 111\u2013122 (2009).","journal-title":"J Neurovirol."},{"key":"37495_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/157015908785777210","volume":"6","author":"SM Stamatovic","year":"2008","unstructured":"Stamatovic, S. M., Keep, R. F. & Andjelkovic, A. V. Brain endothelial cell-cell junctions: how to \u201copen\u201d the blood brain barrier. Curr Neuropharmacol. 6, 179\u2013192 (2008).","journal-title":"Curr Neuropharmacol."},{"key":"37495_CR23","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/j.1478-3231.2010.02211.x","volume":"30","author":"S Lv","year":"2010","unstructured":"Lv, S. et al. Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver Int. 30, 1198\u20131210 (2010).","journal-title":"Liver Int."},{"key":"37495_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11481-007-9091-1","volume":"3","author":"NK Dhillon","year":"2008","unstructured":"Dhillon, N. K. et al. Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2\/CCR2 axis across the blood-brain barrier: implications for HIV-dementia. J Neuroimmune Pharmacol. 3, 52\u201356 (2008).","journal-title":"J Neuroimmune Pharmacol."},{"key":"37495_CR25","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/S0024-3205(00)00566-X","volume":"66","author":"SL Chang","year":"2000","unstructured":"Chang, S. L., Bersig, J., Felix, B., Fiala, M. & House, S. D. Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. Life Sci. 66, 2357\u20132369 (2000).","journal-title":"Life Sci."},{"key":"37495_CR26","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1182\/blood-2010-10-313593","volume":"117","author":"H Yao","year":"2011","unstructured":"Yao, H., Duan, M. & Buch, S. Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood. 117, 2538\u20132547 (2011).","journal-title":"Blood."},{"key":"37495_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3389\/fmicb.2015.01111","volume":"6","author":"S Dash","year":"2015","unstructured":"Dash, S., Balasubramaniam, M., Villalta, F., Dash, C. & Pandhare, J. Impact of cocaine abuse on HIV pathogenesis. Front Microbiol. 6, 1111 (2015).","journal-title":"Front Microbiol."},{"key":"37495_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis, A. D., Skandalis, S. S., Gialeli, C. & Karamanos, N. K. Extracellular matrix structure. Adv Drug Deliv Rev. 97, 4\u201327 (2016).","journal-title":"Adv Drug Deliv Rev."},{"key":"37495_CR29","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/dneu.20954","volume":"71","author":"KM Baeten","year":"2011","unstructured":"Baeten, K. M. & Akassoglou, K. Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev Neurobiol. 71, 1018\u20131039 (2011).","journal-title":"Dev Neurobiol."},{"key":"37495_CR30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","volume":"55","author":"K Gelse","year":"2003","unstructured":"Gelse, K., Poschl, E. & Aigner, T. Collagens\u2013structure, function, and biosynthesis. Adv Drug Deliv Rev. 55, 1531\u20131546 (2003).","journal-title":"Adv Drug Deliv Rev."},{"key":"37495_CR31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.STR.0000119383.76447.05","volume":"35","author":"S Fukuda","year":"2004","unstructured":"Fukuda, S. et al. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke. 35, 998\u20131004 (2004).","journal-title":"Stroke."},{"key":"37495_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF02821717","volume":"19","author":"A Lukes","year":"1999","unstructured":"Lukes, A., Mun-Bryce, S., Lukes, M. & Rosenberg, G. A. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol. 19, 267\u2013284 (1999).","journal-title":"Mol Neurobiol."},{"key":"37495_CR33","first-page":"4629","volume":"41","author":"LA Liotta","year":"1981","unstructured":"Liotta, L. A. et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41, 4629\u20133466 (1981).","journal-title":"Cancer Res."},{"key":"37495_CR34","first-page":"19","volume":"2","author":"D Singh","year":"2015","unstructured":"Singh, D., Srivastava, S. K., Chaudhuri, T. K. & Upadhyay, G. Multifaceted role of matrix metalloproteinases (MMPs). Front Mol Biosci. 2, 19 (2015).","journal-title":"Front Mol Biosci."},{"key":"37495_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-014-3752-y","volume":"42","author":"A Mukherjee","year":"2015","unstructured":"Mukherjee, A. & Swarnakar, A. Implication of matrix metalloproteinases in regulating neuronal disorder. Mol Biol Rep. 42, 1\u201311 (2015).","journal-title":"Mol Biol Rep."},{"key":"37495_CR36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s004010050754","volume":"94","author":"JA Cossins","year":"1997","unstructured":"Cossins, J. A. et al. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol. 94, 590\u2013598 (1997).","journal-title":"Acta Neuropathol."},{"key":"37495_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1365-2990.2006.00729.x","volume":"32","author":"RL Lindberg","year":"2006","unstructured":"Lindberg, R. L. et al. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8\/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Neuropathol Appl Neurobiol. 32, 304\u2013317 (2006).","journal-title":"Neuropathol Appl Neurobiol."},{"key":"37495_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1086\/313922","volume":"31","author":"D Leppert","year":"2000","unstructured":"Leppert, D. et al. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis. 31, 80\u201384 (2000).","journal-title":"Clin Infect Dis."},{"key":"37495_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1365-2249.2002.01855.x","volume":"128","author":"PT Nygardas","year":"2002","unstructured":"Nygardas, P. T. & Hinkkanen, A. E. Up-regulation of MMP-8 and MMP-9 activity in the BALB\/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis. Clin Exp Immunol. 128, 245\u2013254 (2002).","journal-title":"Clin Exp Immunol."},{"key":"37495_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1471-4159.2008.05821.x","volume":"108","author":"W Liu","year":"2009","unstructured":"Liu, W., Hendren, J., Qin, X. J., Shen, J. & Liu, K. J. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J Neurochem. 108, 811\u2013820 (2009).","journal-title":"J Neurochem."},{"key":"37495_CR41","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1161\/01.STR.0000223001.06264.af","volume":"37","author":"A Rosell","year":"2006","unstructured":"Rosell, A. et al. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke. 37, 1399\u20131406 (2006).","journal-title":"Stroke."},{"key":"37495_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2007.12.001","volume":"8","author":"A Rosell","year":"2008","unstructured":"Rosell, A. & Lo, E. H. Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol. 8, 82\u201389 (2008).","journal-title":"Curr Opin Pharmacol."},{"key":"37495_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nm1387","volume":"12","author":"BQ Zhao","year":"2006","unstructured":"Zhao, B. Q. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med. 12, 441\u2013445 (2006).","journal-title":"Nat Med."},{"key":"37495_CR44","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1161\/01.STR.0000083051.93319.28","volume":"34","author":"T Pfefferkorn","year":"2003","unstructured":"Pfefferkorn, T. & Rosenberg, G. A. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke. 34, 2025\u20132030 (2003).","journal-title":"Stroke."},{"key":"37495_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1471-4159.2011.07542.x","volume":"120","author":"Y Gu","year":"2012","unstructured":"Gu, Y. et al. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem. 120, 147\u2013156 (2012).","journal-title":"J Neurochem."},{"key":"37495_CR46","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/nn.3846","volume":"17","author":"AC Smith","year":"2014","unstructured":"Smith, A. C. et al. Synaptic plasticity mediating cocaine relapse requires matrix metalloproteinases. Nat Neurosci. 17, 1655\u20131657 (2014).","journal-title":"Nat Neurosci."},{"key":"37495_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1101\/lm.476207","volume":"14","author":"TE Brown","year":"2007","unstructured":"Brown, T. E. et al. Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference. Learn Mem. 14, 214\u2013223 (2007).","journal-title":"Learn Mem."},{"key":"37495_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2004.08.040","volume":"157","author":"MP Nair","year":"2004","unstructured":"Nair, M. P. et al. Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO. J Neuroimmunol. 157, 56\u201360 (2004).","journal-title":"J Neuroimmunol."},{"key":"37495_CR49","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1111\/febs.14158","volume":"284","author":"P Wilk","year":"2017","unstructured":"Wilk, P. et al. Substrate specificity and reaction mechanism of human prolidase. FEBS J. 284, 2870\u20132885 (2017).","journal-title":"FEBS J."},{"key":"37495_CR50","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00726-008-0051-8","volume":"35","author":"A Surazynski","year":"2008","unstructured":"Surazynski, A., Miltyk, W., Palka, J. & Phang, J. M. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids. 35, 731\u2013738 (2008).","journal-title":"Amino Acids."},{"key":"37495_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2045-8118-10-33","volume":"10","author":"DE Eigenmann","year":"2013","unstructured":"Eigenmann, D. E. et al. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS. 10, 33 (2013).","journal-title":"Fluids Barriers CNS."},{"key":"37495_CR52","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/13550289909021287","volume":"5","author":"Y Persidsky","year":"1999","unstructured":"Persidsky, Y. Model systems for studies of leukocyte migration across the blood - brain barrier. J Neurovirol. 5, 579\u2013590 (1999).","journal-title":"J Neurovirol."},{"key":"37495_CR53","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1126\/science.56036","volume":"191","author":"C Van Dyke","year":"1976","unstructured":"Van Dyke, C., Barash, P. G., Jatlow, P. & Byck, R. Cocaine: plasma concentrations after intranasal application in man. Science. 191, 859\u2013861 (1976).","journal-title":"Science."},{"key":"37495_CR54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/1874143600802010070","volume":"2","author":"K Heard","year":"2008","unstructured":"Heard, K., Palmer, R. & Zahniser, N. R. Mechanisms of acute cocaine toxicity. Open Pharmacol J. 2, 70\u201378 (2008).","journal-title":"Open Pharmacol J."},{"key":"37495_CR55","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1053\/ajem.2000.9282","volume":"18","author":"K Blaho","year":"2000","unstructured":"Blaho, K., Logan, B., Winbery, S., Park, L. & Schwilke, E. Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED. Am J Emerg Med. 18, 593\u2013598 (2000).","journal-title":"Am J Emerg Med."},{"key":"37495_CR56","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.1984.03350140035021","volume":"252","author":"RE Mittleman","year":"1984","unstructured":"Mittleman, R. E. & Wetli, C. V. Death caused by recreational cocaine use. An update. JAMA. 252, 1889\u20131893 (1984).","journal-title":"JAMA."},{"key":"37495_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1520\/JFS16087J","volume":"43","author":"SB Karch","year":"1998","unstructured":"Karch, S. B., Stephens, B. & Ho, C. H. Relating cocaine blood concentrations to toxicity\u2013an autopsy study of 99 cases. J Forensic Sci. 43, 41\u201345 (1998).","journal-title":"J Forensic Sci."},{"key":"37495_CR58","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0379-0738(90)90105-8","volume":"48","author":"FJ Peretti","year":"1990","unstructured":"Peretti, F. J., Isenschmid, D. S., Levine, B., Caplan, Y. H. & Smialek, J. E. Cocaine fatality: an unexplained blood concentration in a fatal overdose. Forensic Sci Int. 48, 135\u2013138 (1990).","journal-title":"Forensic Sci Int."},{"key":"37495_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1749-6632.1994.tb24746.x","volume":"732","author":"RE Galardy","year":"1994","unstructured":"Galardy, R. E. et al. Low molecular weight inhibitors in corneal ulceration. Ann N Y Acad Sci. 732, 315\u2013323 (1994).","journal-title":"Ann N Y Acad Sci."},{"key":"37495_CR60","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/jcb.20631","volume":"96","author":"A Surazynski","year":"2005","unstructured":"Surazynski, A., Liu, Y., Miltyk, W. & Phang, J. M. Nitric oxide regulates prolidase activity by serine\/threonine phosphorylation. J Cell Biochem. 96, 1086\u20131094 (2005).","journal-title":"J Cell Biochem."},{"key":"37495_CR61","doi-asserted-by":"publisher","first-page":"e51387","DOI":"10.1371\/journal.pone.0051387","volume":"7","author":"CK Mantri","year":"2012","unstructured":"Mantri, C. K., Pandhare, J., Mantri, J. & Dash, C. Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b. PLoS One 7, e51387 (2012).","journal-title":"PLoS One."},{"key":"37495_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1462-5822.2009.01379.x","volume":"12","author":"R Mittal","year":"2010","unstructured":"Mittal, R. & Prasadarao, N. V. Nitric oxide\/cGMP signalling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion. Cell Microbiol. 12, 67\u201383 (2010).","journal-title":"Cell Microbiol."},{"key":"37495_CR63","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/320730","volume":"183","author":"F Winkler","year":"2001","unstructured":"Winkler, F., Koedel, U., Kastenbauer, S. & Pfister, H. W. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J Infect Dis. 183, 1749\u20131759 (2001).","journal-title":"J Infect Dis."},{"key":"37495_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","volume":"129","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y., Vanhoutte, P. M. & Leung, S. W. S. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci. 129, 83\u201394 (2015).","journal-title":"J Pharmacol Sci."},{"key":"37495_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/niox.2000.0319","volume":"5","author":"KM Miranda","year":"2001","unstructured":"Miranda, K. M., Espey, M. G. & Wink, D. A. A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite. Nitric Oxide. 5, 62\u201371 (2001).","journal-title":"Nitric Oxide."},{"key":"37495_CR66","doi-asserted-by":"crossref","unstructured":"Kuhar, M. J. Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. Ciba Found Symp. 166, 81\u201389, discussion 89\u201395 (1999).","DOI":"10.1002\/9780470514245.ch6"},{"key":"37495_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-6147(92)90063-C","volume":"13","author":"WL Woolverton","year":"1992","unstructured":"Woolverton, W. L. & Johnson, K. M. Neurobiology of cocaine abuse. Trends Pharmacol Sci. 13, 193\u2013200 (1992).","journal-title":"Trends Pharmacol Sci."},{"key":"37495_CR68","first-page":"43","volume":"163","author":"M Daras","year":"1996","unstructured":"Daras, M. Neurologic complications of cocaine. NIDA Res Monogr. 163, 43\u201365 (1996).","journal-title":"NIDA Res Monogr."},{"key":"37495_CR69","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/13550289809114228","volume":"4","author":"L Zhang","year":"1998","unstructured":"Zhang, L. et al. Cocaine opens the blood-brain barrier to HIV-1 invasion. J Neurovirol. 4, 619\u2013626 (1998).","journal-title":"J Neurovirol."},{"key":"37495_CR70","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0074-7742(09)88011-2","volume":"88","author":"HS Sharma","year":"2009","unstructured":"Sharma, H. S., Muresanu, D., Sharma, A. & Patnaik, R. Cocaine-induced breakdown of the blood-brain barrier and neurotoxicity. Int Rev Neurobiol. 88, 297\u2013334 (2009).","journal-title":"Int Rev Neurobiol."},{"key":"37495_CR71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4613-0407-4_20","volume":"402","author":"AM Fiala","year":"1996","unstructured":"Fiala, A. M. et al. Divergent effects of cocaine on cytokine production by lymphocytes and monocyte\/macrophages: HIV-1 enhancement by cocaine within the blood-brain barrier. Adv Exp Med Biol. 402, 145\u2013156 (1996).","journal-title":"Adv Exp Med Biol."},{"key":"37495_CR72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/CDLI.7.1.96-100.2000","volume":"7","author":"MP Nair","year":"2000","unstructured":"Nair, M. P. et al. Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol. 7, 96\u2013100 (2000).","journal-title":"Clin Diagn Lab Immunol."},{"key":"37495_CR73","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12640-012-9334-7","volume":"23","author":"KH Clark","year":"2013","unstructured":"Clark, K. H., Wiley, C. A. & Bradberry, C. W. Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection. Neurotox Res. 23, 174\u2013188 (2013).","journal-title":"Neurotox Res."},{"key":"37495_CR74","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/ejvs.2002.1598","volume":"23","author":"DM Roach","year":"2002","unstructured":"Roach, D. M. et al. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg. 23, 260\u2013269 (2002).","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"37495_CR75","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","volume":"41","author":"T Klein","year":"2011","unstructured":"Klein, T. & Bischoff, R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids. 41, 271\u2013290 (2011).","journal-title":"Amino Acids."},{"key":"37495_CR76","doi-asserted-by":"publisher","first-page":"2008S","DOI":"10.1093\/jn\/138.10.2008S","volume":"138","author":"JM Phang","year":"2008","unstructured":"Phang, J. M., Pandhare, J. & Liu, Y. The metabolism of proline as microenvironmental stress substrate. J Nutr. 138, 2008S\u20132015S (2008).","journal-title":"J Nutr."},{"key":"37495_CR77","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00726-008-0055-4","volume":"35","author":"A Lupi","year":"2008","unstructured":"Lupi, A., Tenni, R., Rossi, A., Cetta, G. & Forlino, A. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. Amino Acids. 35, 739\u2013752 (2008).","journal-title":"Amino Acids."},{"key":"37495_CR78","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12011-015-0503-4","volume":"171","author":"AK Verma","year":"2016","unstructured":"Verma, A. K. et al. Prolidase-Associated Trace Elements (Mn, Zn, Co, and Ni) in the Patients with Parkinson\u2019s Disease. Biol Trace Elem Res. 171, 48\u201353 (2016).","journal-title":"Biol Trace Elem Res."},{"key":"37495_CR79","first-page":"598028","volume":"2015","author":"AK Verma","year":"2015","unstructured":"Verma, A. K. et al. Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson\u2019s Disease. Parkinsons Dis. 2015, 598028 (2015).","journal-title":"Parkinsons Dis."},{"key":"37495_CR80","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2015.12.036","volume":"613","author":"M Gunes","year":"2016","unstructured":"Gunes, M. et al. Diagnostic performance of increased prolidase activity in schizophrenia. Neurosci Lett. 613, 36\u201340 (2016).","journal-title":"Neurosci Lett."},{"key":"37495_CR81","first-page":"131","volume":"65","author":"B Bahceci","year":"2015","unstructured":"Bahceci, B. et al. Prolidase activity and oxidative stress in patients with schizophrenia: a preliminary study. J Pak Med Assoc. 65, 131\u2013135 (2015).","journal-title":"J Pak Med Assoc."},{"key":"37495_CR82","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jad.2010.09.003","volume":"129","author":"S Selek","year":"2011","unstructured":"Selek, S., Altindag, A., Saracoglu, G., Celik, H. & Aksoy, N. Prolidase activity and its diagnostic performance in bipolar disorder. J Affect Disord. 129, 84\u201386 (2011).","journal-title":"J Affect Disord."},{"key":"37495_CR83","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s10072-013-1346-4","volume":"34","author":"A Arikanoglu","year":"2013","unstructured":"Arikanoglu, A. et al. Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease. Neurol Sci. 34, 2117\u20132121 (2013).","journal-title":"Neurol Sci."},{"key":"37495_CR84","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1346-8138.1997.tb02306.x","volume":"24","author":"T Oono","year":"1997","unstructured":"Oono, T., Fujiwara, Y., Yoshioka, T. & Arata, J. Prolidase activity in chronic wound and blister fluids. J Dermatol. 24, 626\u2013629 (1997).","journal-title":"J Dermatol."},{"key":"37495_CR85","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/ijc.23263","volume":"122","author":"A Surazynski","year":"2008","unstructured":"Surazynski, A. et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer. 122, 1435\u20131440 (2008).","journal-title":"Int J Cancer."},{"key":"37495_CR86","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neulet.2003.11.065","volume":"356","author":"G Bagetta","year":"2004","unstructured":"Bagetta, G. et al. Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurosci Lett. 356, 183\u2013186 (2004).","journal-title":"Neurosci Lett."},{"key":"37495_CR87","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/syn.20537","volume":"62","author":"S Sammut","year":"2008","unstructured":"Sammut, S. & West, A. R. Acute cocaine administration increases NO efflux in the rat prefrontal cortex via a neuronal NOS-dependent mechanism. Synapse. 62, 710\u2013713 (2008).","journal-title":"Synapse."},{"key":"37495_CR88","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/S0002-9440(10)65476-4","volume":"155","author":"Y Persidsky","year":"1999","unstructured":"Persidsky, Y. et al. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol. 155, 1599\u20131611 (1999).","journal-title":"Am J Pathol."},{"key":"37495_CR89","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11481-014-9563-z","volume":"9","author":"F Zenon","year":"2014","unstructured":"Zenon, F., Segarra, A. C., Gonzalez, M. & Mel\u00e9ndez, L. M. Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol. 9, 703\u2013715 (2014).","journal-title":"J Neuroimmune Pharmacol."},{"key":"37495_CR90","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11481-013-9443-y","volume":"8","author":"PJ Gaskill","year":"2013","unstructured":"Gaskill, P. J., Calderon, T. M., Coley, J. S. & Berman, J. W. Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. J Neuroimmune Pharmacol. 8, 621\u201342 (2013).","journal-title":"J Neuroimmune Pharmacol."},{"key":"37495_CR91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-59745-170-3_4","volume":"485","author":"C Aiken","year":"2009","unstructured":"Aiken, C. Cell-free assays for HIV-1 uncoating. Methods Mol Biol. 485, 41\u201353 (2009).","journal-title":"Methods Mol Biol."},{"key":"37495_CR92","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","volume":"72","author":"EJ Platt","year":"1998","unstructured":"Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B. & Kabat, D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol. 72, 2855\u20132864 (1998).","journal-title":"J Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37495-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37495-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37495-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T01:22:05Z","timestamp":1721006525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37495-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37495"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37495-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2567"}}